Американское общество гирудотерапии

Non-Occlusive Mesenteric Ischemia Due to Hirudotherapy: A Case Report

Akalın Ç, Ekmen N (2020) · Cureus · n=1

RCT evidence detailTrial reference
Sample size of this trial compared with other Diabetic Peripheral Neuropathy (Investigational Adjunct) trialsAkalın Ç 20201Zaidi SM 20141
This trial (highlighted) by sample size alongside other indexed Diabetic Peripheral Neuropathy (Investigational Adjunct) trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-patient case report (57-year-old male, Ordu University Training and Research Hospital, Turkey)
Sample size (n)
1
Intervention
Hirudotherapy applied to diabetic foot wounds with subsequent prolonged uncontrollable bleeding and non-occlusive mesenteric ischemia
Comparator
Conventional diabetic foot wound care
Primary endpoint
Identification of severe hirudotherapy adverse event - non-occlusive mesenteric ischemia
Primary result
Excessive bleeding from leech bites caused hypovolemia and non-occlusive mesenteric ischemia; CT showed hepatic portal venous gas and pneumatosis intestinalis; laparotomy revealed necrosis of terminal ileum and entire colon; necrotic segments resected with end-ileostomy; patient discharged day 17
Follow-up duration
17 days hospitalization with surgical resection

Key Findings

  • Non-occlusive mesenteric ischemia from hirudotherapy bleeding
  • Hypovolemia-driven splanchnic hypoperfusion
  • Necrosis of terminal ileum and entire colon required resection
  • End-ileostomy permanent at discharge
  • Critical safety signal for unsupervised hirudotherapy

Limitations

  • Single case - cannot quantify incidence
  • Diabetic foot wound treatment context may amplify risk
  • Unable to establish causal link with full certainty
  • Cannot recommend protocol changes from single case
  • Patient demographics specific to Turkish clinical context

Clinical Implications

Akalın 2020 documents a catastrophic outcome (ischemic bowel necrosis requiring colectomy) from prolonged bleeding after off-label hirudotherapy for diabetic foot wounds. For US clinicians under K040187, this case reinforces the device's restricted indication (postoperative venous congestion in supervised settings) and the dangers of unsupervised use. Critical patient safety education content.

Related Trials

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.